Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24757559 offsetBegin: 541 offsetEnd: 556 A: This is more common in women as mentioned earlier in the Rheumatoid Arthritis section . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24327928 offsetBegin: 1396 offsetEnd: 1423 A: This indicates that the disease may be more common in minority or developing-country settings , an idea that correlates with our findings in Morocco and Egypt . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24757559 offsetBegin: 255 offsetEnd: 277 A: Some studies have reported posterior or panuveitis to be more common in Caucasians compared to African-Americans -LRB- 109 -- 112 -RRB- . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24757559 offsetBegin: 309 offsetEnd: 332 A: It is more frequent in SLE than rheumatoid arthritis and affects more than half of the patients -LRB- 27 , 28 -RRB- . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24757559 offsetBegin: 2 offsetEnd: 22 A: Rheumatoid Arthritis Rheumatoid arthritis -LRB- RA -RRB- is an inflammatory arthritis associated with a variety of extra articular manifestations . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24886568 offsetBegin: 677 offsetEnd: 703 A: More than 60 % of the sick leave periods for disc disorders , hip osteoarthritis and rheumatoid arthritis had duration of 90 days or more . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24757559 offsetBegin: 22 offsetEnd: 33 A: It is three times more common in women than men . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24886568 offsetBegin: 617 offsetEnd: 663 A: Some of the down slope in the older ages might be due to a lesser number at risk in these age groups , as persons with full time disability pension can not be on sick leave and disability pension is more common in older ages . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24886568 offsetBegin: 1377 offsetEnd: 1402 A: Disability pension is more common in older ages and in women and this might lead to lower numbers in these groups -LRB- 28 -RRB- . 
Q:Is Rheumatoid Arthritis more common in men or women? Document:http://www.ncbi.nlm.nih.gov/pubmed/24757559 offsetBegin: 797 offsetEnd: 819 A: Presence of PUK or necrotizing scleritis in patients with rheumatoid arthritis indicates severe systemic disease necessitating immunosuppressive therapy -LRB- 16 -RRB- . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 842 offsetEnd: 854 A: Finally , the membrane collapses on the dorsum of the animal . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 459 offsetEnd: 493 A: Center image : tissue obtained from the paraspinal ridges from which the base of the membrane arises -LRB- for the macroscopic appearance see the tissue marked with the arrow in Figure 2k -RRB- . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 42 offsetEnd: 68 A: HRS oversaw the study , provided the MSU crystals and initial instruction in the use of the air pouch model , and edited the manuscript . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 679 offsetEnd: 694 A: Figure 2Key steps in the separation of the membrane from the overlying soft tissues . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 179 offsetEnd: 209 A: Gene profiling of intact tissues is potentially hampered by the presence of adjacent noninflamed tissue , which increases the complexity of the tissue and introduces background ` noise ' . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 82 offsetEnd: 98 A: Figure 3a illustrates the plane of dissection between the membrane and the overlying subcutaneous tissue . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 303 offsetEnd: 335 A: Potential roles of PUMA-g , TREM-1 , Irg1 , PROK-2 and Hdc in the pathogenesis of crystal inflammationWe validated the induction of six of the most highly over-expressed genes by qPCR . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 1241 offsetEnd: 1263 A: This suggested the presence of small remnants of fat and muscle on the membranes that persisted despite the histologically clean dissection . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/23455712 offsetBegin: 519 offsetEnd: 547 A: This may be relevant as Toxoplasma gondii infection in the CNS results in lesions of the frontal and parietal cortex , with sparing of the cerebellum40 ,41 . 
Q:What is the function of the mammalian gene Irg1? Document:http://www.ncbi.nlm.nih.gov/pubmed/18522745 offsetBegin: 804 offsetEnd: 821 A: The instrument follows a path of least resistance between the membrane and the overlying soft tissues . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/23658839 offsetBegin: 1188 offsetEnd: 1215 A: 4C -RRB- such that the methyl donor supplementation of the dam decreased the overall level of activity regardless of the fat content of the maternal diet . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/23658839 offsetBegin: 1020 offsetEnd: 1051 A: 3C -RRB- such that the methyl donor supplementation of the dam decreased the overall level of activity in female offspring , regardless of the fat content of the maternal diet . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/23724145 offsetBegin: 2352 offsetEnd: 2389 A: The chromosomal DNA will then be at the mercy of the DNA methyltransferases which are expected to be up-regulated in the transformed cells , and the hypermethylation phenotype observed in bladder cancers may thus be manifested . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/22438930 offsetBegin: 38 offsetEnd: 81 A: Secondly , chronic treatment of methionine , the precursor of SAM and the methyl donor of DNA methylation reaction , significantly attenuated the establishment of CPP at a higher dose of cocaine and abolished the establishment of CPP at lower dose cocaine . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/23561294 offsetBegin: 771 offsetEnd: 801 A: The intensity of the band was higher than that of LUCH even when the amount of LUCH DNA was twice the amount of LUCL DNA -LRB- Figure 1C -RRB- . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/24022817 offsetBegin: 67 offsetEnd: 93 A: The quantitative participation of each of the methyl donors in the daily net flow of methyl groups has not been thoroughly examined -LRB- 33,34 -RRB- . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/24205358 offsetBegin: 196 offsetEnd: 232 A: Plasmid pUP41 was incubated with M. SssI in the absence of the methyl donor SAM , then introduced by electroporation into the E. coli ER2357 ung strain deficient in the repair of uracil containing DNA . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/23437105 offsetBegin: 184 offsetEnd: 208 A: DNA methylation involves addition of a methyl group at the 5th-C position of cytosine residue in DNA which is catalyzed by DNA methyltransferases . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/22303319 offsetBegin: 287 offsetEnd: 324 A: Since folate is a key dietary source of methyl groups for synthesis of S-adenosyl methionine -LRB- SAM -RRB- -- the universal methyl donor -- it is an attractive candidate nutrient for the modulation of DNA methylation . 
Q:What is the methyl donor of DNA (cytosine-5)-methyltransferases? Document:http://www.ncbi.nlm.nih.gov/pubmed/23658839 offsetBegin: 1496 offsetEnd: 1553 A: Because , the primary goal was to determine whether methyl donor supplementation would block or reverse phenotypic changes driven by maternal consumption of the HF diet , and because methyl donor supplementation could have effects independent of the fat content of the maternal diet , inclusion of the control + Met group was a necessary control . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/19337550 offsetBegin: 291 offsetEnd: 310 A: The activation of thrombin occurs on the surface of activated platelets and requires formation of a prothrombinase complex . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/19337550 offsetBegin: 1169 offsetEnd: 1190 A: However , the three higher dose arms of the study were stopped prematurely because of increased rates of major bleeding . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/19337550 offsetBegin: 0 offsetEnd: 26 A: Current focus of antithrombotic development The rationale behind the development of antithrombotics is based on an understanding of the coagulation cascade -LRB- Figure 1 -RRB- . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/19337550 offsetBegin: 319 offsetEnd: 364 A: The utility of VKAs is limited by the difficulty of managing them , the requirement of frequent monitoring and the necessity for dose adjustment to limit the adverse consequences of a narrow therapeutic window , multiple food and drug interactions , and variable pharmacology . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/19337550 offsetBegin: 365 offsetEnd: 383 A: The primary efficacy outcome was the composite of symptomatic recurrent VTE and deterioration of the thrombotic burden . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/23470494 offsetBegin: 175 offsetEnd: 204 A: Under the questionable assumption of equal clinical importance of bleedings and the components of MACEs , the net clinical benefit -LRB- NNTB minus NNTH -RRB- was unfavourable overall . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/23470494 offsetBegin: 901 offsetEnd: 963 A: Strengths and limitationsThe strengths of this study are the inclusion of all published randomized , placebo-controlled phase II and III studies of novel oral anticoagulants ; that risk of publication bias was very low as assessed by two methods ; that the very few data points that were unavailable in the publications were successfully retrieved from the authors of the studies . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/23470494 offsetBegin: 973 offsetEnd: 1017 A: The groups of patients receiving at least one dose of the studied dosages of the novel oral anticoagulants ximelagatran , dabigatran , and darexaban in the phase II trials ESTEEM ,11 REDEEM ,14 and RUBY-1 ,15 respectively , were included in the meta-analysis . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/19337550 offsetBegin: 805 offsetEnd: 859 A: In a pooled analysis of the RE-MODEL , RE-MOBILIZE , and RE-NOVATE studies -LRB- Caprini et al 2007 -RRB- , major VTE and VTE-related death occurred in 3.3 % of the enoxaparin group versus 3.0 % of the dabigatran etexilate 220 mg group and 3.8 % of the dabigatran etexilate 150 mg group . 
Q:What is the mechanism of action of anticoagulant medication Dabigatran? Document:http://www.ncbi.nlm.nih.gov/pubmed/19337550 offsetBegin: 1013 offsetEnd: 1113 A: Dabigatran is currently being investigated in three further phase III trials : RE-LY , a study comparing the efficacy and safety of dabigatran with warfarin for the prevention of stroke and systemic embolism in patients with non-valvular AF ; RE-COVER , a randomized study comparing the efficacy and safety of dabigatran etexilate with warfarin for the treatment of acute symptomatic VTE , following initial treatment with a parenteral anticoagulant ; and RE-MEDY , a randomized , active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate compared with warfarin , for the secondary prevention of VTE . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 218 offsetEnd: 239 A: The production of itaconic acid requires continuous aeration and already a short interruption of oxygen decreases the itaconic acid yield . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 1431 offsetEnd: 1451 A: The activity of the cis-aconitic acid decarboxylase is crucial for the performance of the whole itaconic acid biosynthesis pathway . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 356 offsetEnd: 373 A: The latter review covers the industrial production of itaconic acid and the applications of this product . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 274 offsetEnd: 315 A: Especially , for the production of polymers it is of interest , because in the future it can function as a substitute for acrylic and methacrylic acid used for the production of plastics -LRB- Okabe et al. , 2009 -RRB- . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 0 offsetEnd: 39 A: CATABOLIZATION OF ITACONIC ACID Much is known about the biosynthesis of itaconic acid and the underlying enzymatic mechanisms , but for a complete biochemical picture of a certain metabolite , also the knowledge about its degradation is necessary . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 26 offsetEnd: 73 A: The biosynthesis of itaconic acid was for a long time hotly debated , because it was not clear whether itaconic acid arises from a pathway including parts of the tricarboxylic acid -LRB- TCA -RRB- cycle or an alternative pathway via citramalate or the condensation of acetyl-CoA . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 364 offsetEnd: 383 A: The unique and crucial step in the biosynthesis pathway is the decarboxylation of cis-aconitic acid toward itaconic acid . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 0 offsetEnd: 32 A: METABOLIC ENGINEERING OF THE ITACONIC ACID PATHWAY IN A. terreus AND A. niger The levels of itaconic acid which were reached with A. terreus are currently limited to about 85 g\/L . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 258 offsetEnd: 273 A: Indeed , the expression of this gene leads to an increased itaconic acid production . 
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 0 offsetEnd: 31 A: OUTLOOK Itaconic acid as a renewable organic acid is of growing interest for the chemical industry , because of its potential to replace crude oil based products like acrylic acid . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 1638 offsetEnd: 1666 A: The strengths of this study include the relatively large number of TRH cases available in the ALLHAT\/GenHAT study , including large numbers of African Americans with TRH . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 2 offsetEnd: 23 A: Conclusions Improving prevention and treatment of TRH will be enhanced with a thorough knowledge of the genetic architecture of TRH . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 335 offsetEnd: 374 A: Therefore , we assessed genetic associations with TRH among African American and white participants in the Genetics of Hypertension Associated Treatment -LRB- GenHAT -RRB- study using 78 candidate genetic polymorphisms implicated in the development of hypertension and CVD . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 40 offsetEnd: 72 A: This research contributes to our understanding of the genetic basis of TRH , and further studies of TRH may help us reach the goal of better clinical outcomes for hypertensive patients . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 401 offsetEnd: 435 A: Strengths of ALLHAT\/GenHAT for the current study of TRH are that drug utilization and dose optimization are well documented , in addition to adherence data , resulting in less potential misclassification of TRH . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 331 offsetEnd: 359 A: Therefore , the cases and controls selected for the current effort represent extremes of the distribution of number of antihypertensive medications required to control HTN in GenHAT . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 1259 offsetEnd: 1278 A: To varying degrees , all three of these genes have been previously studied in the context of hypertension . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 981 offsetEnd: 996 A: Analyses of the full ALLHAT cohort for CVD outcomes in TRH are currently underway . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 113 offsetEnd: 126 A: Table 3 shows the association of the ALLHAT clinical outcomes with TRH . 
Q:What is the role of TRH in hypertension? Document:http://www.ncbi.nlm.nih.gov/pubmed/24288596 offsetBegin: 1343 offsetEnd: 1373 A: Previous studies have assessed the effect of MMP genes on hypertension and its sequelae , with an over expression of MMP found in hypertension -LRB- 29 -- 32 -RRB- . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 1048 offsetEnd: 1071 A: There are also cytoplasmic intermediate filaments in C. elegans , albeit quite different in primary sequence to mammalian desmin -LRB- 63 -RRB- . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 5406 offsetEnd: 5440 A: Similar-sized desmin proteolytic fragments were observed in samples prepared from MCF7 cells transfected with A337P desmin and for those co-transfected with the combination of WT desmin and R120G CRYAB -LRB- figure 6b -RRB- . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 4547 offsetEnd: 4560 A: Note the aggregates in those cells co-transfected with desmin and R120G CRYAB . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 785 offsetEnd: 812 A: Desmin is a type III intermediate filament protein expressed in muscle , which suggests that the interaction of desmin with CRYAB is key to understanding DRM . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 661 offsetEnd: 720 A: There have been many suggestions to explain the tissue-specific pathologies associated with sHSP mutations -LRB- 34 -- 40 -RRB- , but we propose that the specific intermediate filament expression pattern must be considered as a key factor in any sHSP-based pathology as we consider the intermediate filament -- sHSP complex to be a functional unit -LRB- 41,42 -RRB- . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 885 offsetEnd: 899 A: Figure 2.Co-sedimentation of WT and arginine mutant sHSPs to desmin filaments in vitro . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 5066 offsetEnd: 5104 A: -LRB- a -RRB- Cell viability was measured in MCF7 cells transiently transfected with WT desmin , A337P desmin , R120G CRYAB alone or co-transfected with WT desmin and R120G CRYAB at a 1 : 1 molar ratio . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 278 offsetEnd: 317 A: This was faithfully replicated in a knock-in mouse model of the R120G CRYAB disease-causing mutation , with desmin aggregation in muscles and the additional observation of increased vimentin aggregation in the lenses of these animals -LRB- 23 -RRB- . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 4958 offsetEnd: 4973 A: Co-transfection of R120G CRYAB with WT desmin induced a significant reduction in cell viability . 
Q:Are there any desmins present in plants? Document:http://www.ncbi.nlm.nih.gov/pubmed/23530264 offsetBegin: 2922 offsetEnd: 2937 A: Desmin assembled alone has a higher stiffness compared with when WT CRYAB is present . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 5007 offsetEnd: 5019 A: g010Figure 10PAN RNA interacts with demethylases and the histone methyltransferase MLL2 . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 750 offsetEnd: 767 A: PAN RNA could serve as the conduit for changes in histone markings across the KSHV genome . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 728 offsetEnd: 746 A: We also demonstrate that PAN RNA interacts with demethylases UTX and JMJD3 and the histone methytransferase MLL2 . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 4686 offsetEnd: 4715 A: The observation that JMJD3 and UTX interact with the K-Rta promoter suggests that the removal of the repressive histone mark is a possible mechanism for activation of transcription . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 5422 offsetEnd: 5457 A: These data strongly suggest that PAN RNA expression leads to the activation of KSHV gene expression by facilitating changes in histone modifications by bridging and interaction of chromatin modifying enzymes with the KSHV genome . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 4089 offsetEnd: 4129 A: Further , it was demonstrated that when the lytic cycle is induced , KSHV genomes show an increase in activation histone marks such as H3K4me3 and acetylated histones and a decrease in the repressive H3K27me3 mark -LRB- 23 -RRB- . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 1024 offsetEnd: 1059 A: The interaction of histone proteins by PAN RNA could account for the general decrease in viral transcription that was observed in the absence of PAN RNA , chromatin remains in a less open configuration . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 4923 offsetEnd: 4942 A: These data indicate that PAN RNA interacts with the demethylases UTX and JMJD3 and with the MLL2 methyltransferase . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 0 offsetEnd: 33 A: Introduction Kaposi 's sarcoma associated herpesvirus -LRB- KSHV -RRB- is an oncogenic herpesvirus that is the cause of Kaposi 's sarcoma and body cavity lymphoma -LRB- 1 -RRB- -- -LRB- 4 -RRB- . 
Q:How do histone methyltransferases cause histone modification? Document:http://www.ncbi.nlm.nih.gov/pubmed/22589717 offsetBegin: 191 offsetEnd: 224 A: After amplifying the GalK-KanR cassette using Easy-A taq polymerase -LRB- Stratagene -RRB- , the PCR product was subjected to DpnI cleavage and subsequent agarose gel purification to remove all residual plasmid template . 
